RG1678 protective_against negative symptoms
Evidence from:
primary |
all sources
Evidence (1 sources)
Glutamatergic transmission in schizophrenia: from basic research to clinical practice.
(2012)
PMID:22297716
cited
RG1678 ... showed significant improvement in negative symptoms ... P <0.05
confidence: 0.96